Isradipine

Lomir

BrazilCancelledAuthorised 20 Aug 1998

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Lomir Sro Caps 5MGSaudi Arabia · NovartisSame brand
Lomir Tab 2.5MGSaudi Arabia · NovartisSame brand
ClivotenItaly · Capsula rigida a rilascio prolungato · Italfarmaco S.P.A.Same substance
AnyNew Zealand · Cap 2.5 mgSame substance
IsradipineUnited States · 2.5MG, 5MG · capsule · Elite Labs INCSame substance
DynacircUnited States · 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · capsule · Smithkline Beecham

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Isradipine

Lomir

BrazilCancelledAuthorised 20 Aug 1998

Ask Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Dynacirc CRUnited States · 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet, extended release · Glaxosmithkline LLC

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Isradipine
Register: Brazil (Anvisa)
Status: Cancelled
Status in the register: Inativo
Authorised: 20 Aug 1998
Registration: 100680072
Marketing authorisation holder: Novartis Biociencias S.A
Procedure: Registered